Cite
APA Citation
Reid, T., Oronsky, B., Scicinski, J., Scribner, C. L., Knox, S. J., Ning, S., Peehl, D. M., Korn, R., Stirn, M., Carter, C. A., Oronsky, A., Taylor, M. J., Fitch, W. L., Cabrales, P., Kim, M. M., Burris, H. A., Lao, C. D., Abrouk, N. E. D., Fanger, G. R., & Infante, J. R. (n.d.). safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study. Lancet oncology, 16(9), 1133–1142. http://access.bl.uk/ark:/81055/vdc_100051217362.0x000030